Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent

High levels of expression of glycoprotein non-metastatic B (gpNMB) in triple negative breast cancer (TNBC) and its association with metastasis and recurrence make it an attractive target for therapy with the antibody drug conjugate, glembatumumab vedotin (CDX-011). This report describes the developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Marquez-Nostra, Bernadette V., Lee, Supum, Laforest, Richard, Vitale, Laura, Nie, Xingyu, Hyrc, Krzysztof, Keler, Tibor, Hawthorne, Thomas, Hoog, Jeremy, Li, Shunqiang, Dehdashti, Farrokh, Ma, Cynthia X., Lapi, Suzanne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732808/
https://www.ncbi.nlm.nih.gov/pubmed/29262642
http://dx.doi.org/10.18632/oncotarget.22228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732808/
https://www.ncbi.nlm.nih.gov/pubmed/29262642
http://dx.doi.org/10.18632/oncotarget.22228

Ejemplares similares